Back to results
US 2021/0260000 A1Published application
The use of actarit in the prophylaxis or treatment of renal fibrosis or kidney disease
AssigneeAlgernon Pharmaceuticals Inc.
InventorMark WILLIAMS
Life of this patent
Estimating the term…
Abstract
Iguratimod, Repirinast, Lobenzarit, Actarit, Ifenprodil, Bemithyl, Bromantane, Emoxypine, Udenafil, and/or Istradefylline are used for the treatment or prophylaxis of renal fibrosis, kidney disease, or chronic kidney disease in a subject.
Claims11
1-116. (canceled)
A method for the treatment or prophylaxis of renal fibrosis or kidney disease in a subject, the method comprising:
- administering a therapeutically effective amount of Suplatast Tosylate to the subject.
A method for the treatment or prophylaxis of renal fibrosis or kidney disease in a subject, the method comprising:
- administering a therapeutically effective amount of Bromantane to the subject.
Dependencies are inferred from the claim text.